Illustration of pembrolizumab (marketed under the name Keytruda), a drug that treats various types of cancers. Pembrolizumab is a therapeutic antibody that binds to and blocks programmed cell death protein 1 (PD-1) located on lymphocyte white blood cells.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG35143117
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
keytrudapembrolizumabimmunotherapyoncologyoncologicalcancermalignancycancerousmalignantimmuno-oncologymelanomalungcancerheadandnecksquamouscellcarcinomaantibodypharmaceuticaldrugdevelopmentproteinstructurehealthcaremedicinemedicalpharmacologydrugpharmacologicaloncologyoncologicalcancermalignancycancerousmalignantlymphocytestcellsprogrammedcelldeathprotein13dthreedimensionalnobodyno-onemoleculemolecularmodelmolecularstructureartworkillustrationbiochemistrybiochemicalbiologybiologicalcgidigitally-generated
13dandantibodyartworkbiochemicalbiochemistrybiologicalbiologycancercancercancercancerouscancerouscarcinomacellcellcellscgideathdevelopmentdigitally-generateddimensionaldrugdrugheadhealthcareillustrationimmuno-oncologyimmunotherapykeytrudalunglymphocytesmalignancymalignancymalignantmalignantmedicalmedicinemelanomamodelmolecularmolecularmoleculeneckno-onenobodyoncologicaloncologicaloncologyoncologypembrolizumabpharmaceuticalpharmacologicalpharmacologyprogrammedproteinproteinsquamousstructurestructuretthree